Fares Qeadan , Emma M. Federico , Benjamin Tingey , Atif Zafar , Andrew P. Carlson
{"title":"阿片类药物使用障碍与脑动脉瘤破裂的关系","authors":"Fares Qeadan , Emma M. Federico , Benjamin Tingey , Atif Zafar , Andrew P. Carlson","doi":"10.1016/j.drugalcdep.2025.112896","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>The association between opioid use disorder (OUD) and cerebral aneurysm rupture has been suggested in recent studies. However, these studies are limited to small sample sizes and lack data on medications for opioid use disorder (MOUD). We investigate the association between OUD and cerebral aneurysm rupture in a large database.</div></div><div><h3>Methods</h3><div>A retrospective cohort study was conducted using de-identified electronic health record (EHR) data from Oracle EHR Real-World Data™ (OERWD). Cox proportional hazard regressions were conducted to assess the association between OUD and aneurysm rupture, and the association of MOUD with aneurysm rupture, over different years of follow-up.</div></div><div><h3>Results</h3><div>Patients with OUD (n = 584,125), compared to non-exposures (n = 1752,375) had 54 % higher risk (adjusted hazard ratio (aHR) [95 % confidence interval (CI)]: 1.54 [1.34, 1.76]) of cerebral aneurysm rupture within one year of follow-up and 28 % higher risk (aHR [95 % CI]: 1.28 [1.14, 1.44]) within five years of follow-up. Additionally, patients with OUD and MOUD treatment (n = 83,164), compared to those with OUD but without MOUD (n = 410,466), had 25 % lower risk (aHR [95 % CI]: 0.75 [0.55, 1.01]) of cerebral aneurysm rupture in one year of follow-up and 30 % lower risk (aHR [95 % CI]: 0.70 [0.51, 0.98]) in five years of follow-up.</div></div><div><h3>Conclusions</h3><div>This research identified OUD as a significant risk factor, and MOUD as a protective factor both significant and on the boundary of significance in certain years of follow-up for cerebral aneurysm rupture. These results provide important insight that could encourage future targeted strategies for early intervention and prevention in such patients.</div></div>","PeriodicalId":11322,"journal":{"name":"Drug and alcohol dependence","volume":"276 ","pages":"Article 112896"},"PeriodicalIF":3.6000,"publicationDate":"2025-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The association of opioid use disorder with cerebral aneurysm rupture\",\"authors\":\"Fares Qeadan , Emma M. Federico , Benjamin Tingey , Atif Zafar , Andrew P. Carlson\",\"doi\":\"10.1016/j.drugalcdep.2025.112896\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>The association between opioid use disorder (OUD) and cerebral aneurysm rupture has been suggested in recent studies. However, these studies are limited to small sample sizes and lack data on medications for opioid use disorder (MOUD). We investigate the association between OUD and cerebral aneurysm rupture in a large database.</div></div><div><h3>Methods</h3><div>A retrospective cohort study was conducted using de-identified electronic health record (EHR) data from Oracle EHR Real-World Data™ (OERWD). Cox proportional hazard regressions were conducted to assess the association between OUD and aneurysm rupture, and the association of MOUD with aneurysm rupture, over different years of follow-up.</div></div><div><h3>Results</h3><div>Patients with OUD (n = 584,125), compared to non-exposures (n = 1752,375) had 54 % higher risk (adjusted hazard ratio (aHR) [95 % confidence interval (CI)]: 1.54 [1.34, 1.76]) of cerebral aneurysm rupture within one year of follow-up and 28 % higher risk (aHR [95 % CI]: 1.28 [1.14, 1.44]) within five years of follow-up. Additionally, patients with OUD and MOUD treatment (n = 83,164), compared to those with OUD but without MOUD (n = 410,466), had 25 % lower risk (aHR [95 % CI]: 0.75 [0.55, 1.01]) of cerebral aneurysm rupture in one year of follow-up and 30 % lower risk (aHR [95 % CI]: 0.70 [0.51, 0.98]) in five years of follow-up.</div></div><div><h3>Conclusions</h3><div>This research identified OUD as a significant risk factor, and MOUD as a protective factor both significant and on the boundary of significance in certain years of follow-up for cerebral aneurysm rupture. These results provide important insight that could encourage future targeted strategies for early intervention and prevention in such patients.</div></div>\",\"PeriodicalId\":11322,\"journal\":{\"name\":\"Drug and alcohol dependence\",\"volume\":\"276 \",\"pages\":\"Article 112896\"},\"PeriodicalIF\":3.6000,\"publicationDate\":\"2025-09-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Drug and alcohol dependence\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0376871625003497\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PSYCHIATRY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug and alcohol dependence","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0376871625003497","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PSYCHIATRY","Score":null,"Total":0}
The association of opioid use disorder with cerebral aneurysm rupture
Background
The association between opioid use disorder (OUD) and cerebral aneurysm rupture has been suggested in recent studies. However, these studies are limited to small sample sizes and lack data on medications for opioid use disorder (MOUD). We investigate the association between OUD and cerebral aneurysm rupture in a large database.
Methods
A retrospective cohort study was conducted using de-identified electronic health record (EHR) data from Oracle EHR Real-World Data™ (OERWD). Cox proportional hazard regressions were conducted to assess the association between OUD and aneurysm rupture, and the association of MOUD with aneurysm rupture, over different years of follow-up.
Results
Patients with OUD (n = 584,125), compared to non-exposures (n = 1752,375) had 54 % higher risk (adjusted hazard ratio (aHR) [95 % confidence interval (CI)]: 1.54 [1.34, 1.76]) of cerebral aneurysm rupture within one year of follow-up and 28 % higher risk (aHR [95 % CI]: 1.28 [1.14, 1.44]) within five years of follow-up. Additionally, patients with OUD and MOUD treatment (n = 83,164), compared to those with OUD but without MOUD (n = 410,466), had 25 % lower risk (aHR [95 % CI]: 0.75 [0.55, 1.01]) of cerebral aneurysm rupture in one year of follow-up and 30 % lower risk (aHR [95 % CI]: 0.70 [0.51, 0.98]) in five years of follow-up.
Conclusions
This research identified OUD as a significant risk factor, and MOUD as a protective factor both significant and on the boundary of significance in certain years of follow-up for cerebral aneurysm rupture. These results provide important insight that could encourage future targeted strategies for early intervention and prevention in such patients.
期刊介绍:
Drug and Alcohol Dependence is an international journal devoted to publishing original research, scholarly reviews, commentaries, and policy analyses in the area of drug, alcohol and tobacco use and dependence. Articles range from studies of the chemistry of substances of abuse, their actions at molecular and cellular sites, in vitro and in vivo investigations of their biochemical, pharmacological and behavioural actions, laboratory-based and clinical research in humans, substance abuse treatment and prevention research, and studies employing methods from epidemiology, sociology, and economics.